← Sanara MedTech Inc. SMTI
Market Price
$34.14
Market Cap
$313.04M
P/E Ratio
N/A
Revenue (FY 2025)
↑19.0% YoY
$103.12M
3-Yr CAGR: 31.0%
Net Income
↓-288.7% YoY
-$37.56M
Net Margin: -36.4%
Free Cash Flow
↑1,041.1% YoY
$2.16M
FCF Yield: 0.69%
EPS (Diluted)
↓-282.5% YoY
$-4.36
Basic: $-4.36
Return on Equity
Efficiency
-632.5%
ROA: -3,959.7%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (SMTI)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $5.5M | — | $4.6M | $-0.4M | — | $-0.01 | — | $0.4M | $0.4M | — |
| FY 2017 | $6.3M | +14.5% | $5.5M | $0.3M | +179.7% | — | +100.0% | $-0.1M | $-0.2M | -145.2% |
| FY 2018 | $5.8M | -7.4% | $5.3M | $-0.6M | -281.3% | — | — | $0.3M | $0.3M | +246.2% |
| FY 2019 | $11.8M | +101.6% | $10.6M | $-2.8M | -368.6% | $-1.32 | — | $-2.2M | $-2.4M | -974.8% |
| FY 2020 | $15.6M | +32.5% | $14.0M | $-4.4M | -54.8% | $-0.76 | +42.4% | $-4.0M | $-4.6M | -94.8% |
| FY 2021 | $24.1M | +54.9% | $21.8M | $-8.0M | -83.5% | $-1.08 | -42.1% | $-4.8M | $-5.0M | -8.9% |
| FY 2022 | $45.8M | +89.9% | $39.5M | $-7.9M | +0.7% | $-1.00 | +7.4% | $-5.6M | $-5.7M | -14.3% |
| FY 2023 | $65.0M | +41.8% | $57.1M | $-4.3M | +45.8% | $-0.52 | +48.0% | $-3.2M | $-3.5M | +38.4% |
| FY 2024 | $86.7M | +33.4% | $78.5M | $-9.7M | -124.6% | $-1.14 | -119.2% | $-0.0M | $-0.2M | +93.5% |
| FY 2025 | $103.1M | +19.0% | $95.6M | $-37.6M | -288.7% | $-4.36 | -282.5% | $6.8M | $2.2M | +1,041.1% |
Valuation
Market Price
$34.14
Market Cap
$313.04M
Enterprise Value
$342.43M
P/E Ratio
N/A
P/B Ratio
52.68
FCF Yield
0.69%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
92.71%
Operating Margin
7.08%
Net Margin
-36.43%
Return on Equity (ROE)
-632.53%
Return on Assets (ROA)
-3,959.71%
Asset Turnover
108.70x
Revenue 3-Yr CAGR
31.03%
Financial Health & Liquidity
Current Ratio
0.05
Cash Ratio
0.89
Debt / Equity
7.741
Debt / Assets
48.461
Cash & Equivalents
$16.58M
Total Debt
$45.97M
Book Value / Share
$0.65
Cash Flow Efficiency
Operating Cash Flow
$6.79M
Capital Expenditures (CapEx)
$4.63M
Free Cash Flow
$2.16M
OCF / Revenue
6.58%
FCF / Revenue
2.10%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-4.36
EPS (Basic)
$-4.36
Dividends / Share
N/A
Book Value / Share
$0.65
EPS YoY Growth
-282.46%
Balance Sheet (FY 2025)
Total Assets
$948.62K
Total Liabilities
$18.63M
Stockholders' Equity
$5.94M
Current Assets
$948.62K
Current Liabilities
$18.63M